Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. increased its holdings in Dyne Therapeutics, Inc. by 9% in the third quarter, acquiring an additional 278,466 shares and bringing its total ownership to 3,365,245 shares valued at approximately $42.6 million. Other institutional investors have also modified their stakes in DYN, which has a MarketBeat consensus rating of "Moderate Buy" and a target price of $35.14. Additionally, Director Brian S. Posner recently purchased 3,000 shares, increasing his personal holdings to 11,500 shares.
https://www.marketbeat.com/instant-alerts/filing-dyne-therapeutics-inc-dyn-shares-bought-by-jpmorgan-chase-co-2026-03-22/